Intriguingly, all three colon cancer-associated mutants (E319G, E406X, M435I) showed diminished enzymatic activity on the cell surface comparable to the mock control, whereas the pancreatic cancer variant P417Q exhibited peptide cleavage even above ADAM17 wild type level (Figure 2G). This evidence concerns the gene ADAM17 and pancreatic neoplasm.